CD267 (TACI) Antibody, anti-human, PE-Vio® 670, REAfinity™, 100 tests in 200 µL
文献支持

CD267 (TACI) Antibody, anti-hu

man, PE-Vio® 670, REAfinity™, 100 tests in 200 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-133-373
  • 2025年12月09日
  • Flow cytometry
  • human cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      CD267 (TACI)

    • 亚型

      recombinant human IgG1

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,4-8℃

    • 克隆性

      REA1229

    • 标记物

      PE-Vio 670

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi Biotec

    • 宿主

      human cell line

    • 应用范围

      Flow cytometry

    • 浓度

      1:50

    • 抗体英文名

      CD267 (TACI) Antibody, anti-human, REAfinity™

    • 抗体名

      CD267 (TACI) Antibody, anti-human, REAfinity™

    • 规格

      100 tests in 200 µL

    Identification and enumeration of CD267 (TACI)+ cells by flow cytometryClone REA1229 recognizes the human CD267 antigen, a 32 kDa type III transmembrane protein belonging to the TNF receptor superfamily. CD267 as receptor binds to BAFF and APRIL and plays an important role in the stimulation of B- and T-cell function and in the regulation of humoral immunity. CD267 expression is found in CD27+ memory B cells, tonsillar and bone marrow plasma cells, in a subpopulation of activated CD27-, non GC cells and in a small subset of naïve blood and tonsil B cells. CD267 is also expressed on many lymphomas such as multiple myeloma and Hodgkin and non-Hodgkin lymphomas. Mutations in CD267 are often associated with common variable immunodeficiency in humans. Signaling via CD267 leads to activation of the transcription factors NFAT, AP1, and NF-kappa-B. | Additional information: Clone REA1229 displays negligible binding to Fc receptors.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Salzer, U. et al. (2005) Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37 (8): 820–828. | Mackay, F. et al. (2008) TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev. 19 (3–4): 263–276.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月11日询价
    ¥1397
    北京达科为生物技术有限公司
    2025年07月07日询价
    ¥2700
    上海齐源生物科技有限公司
    2025年07月13日询价
    ¥2299
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2025年08月12日询价
    文献支持
    CD267 (TACI) Antibody, anti-human, PE-Vio® 670, REAfinity™, 100 tests in 200 µL
    询价